皇冠比分网_皇冠即时比分-专为体育打造

图片
Home » News and 皇冠比分网_皇冠即时比分-专为体育打造 » Display News Item

Display News Item

20.02.2017

Publication of the PIONEER clinical trials at the New England Journal of Medicine with the participation of UoA

20/2/2017

The results of the multicenter PIONEER trials were published in the?New England Journal of Medicine. Among the co-authors of the paper was Dr.?Evangelos J. Giamarellos-Bourboulis,?Associate Professor of Internal Medicine?at the Medical School of the National and Kapodistrian University of 皇冠比分网_皇冠即时比分-专为体育打造.?The paper analyzes the efficacy of adalimumab in hidradenitis suppurativa. The OutPatients Department of Immunology of Infections at ATTIKON University hospital that is under the supervision of Dr. Giamarellos was the top recruiter global site. The value of this publication is further outscored by the granted registration of adalimumab for hidradenitis suppurativa by both the Food and Drug Administration of USA and by the European Medicines Agency based on these results. The publication is available at the following link.

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1504370